The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery

The effect of topical 0.05% cyclosporine on recurrence following pterygium surgery

Ece Turan-Vural&sup1;, Banu Torun-Acar&sup1;, S Argun Kivanc&sup2;, Suphi Acar&sup1;&sup1;Haydarpaşa Numune Education and Research Hospital, Ophthalmology Clinic, Istanbul, Turkey; &sup2;Umranıye Education and Research Hospital, Ophthalmology Clinic, I...

Full description

Bibliographic Details
Main Authors:	Turan-Vural E, Torun-Acar BT, Kivanc SA, Acar S
Format:	Article
Language:	English
Published:	Dove Medical Press 2011-06-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/the-effect-of-topical-005-cyclosporine-on-recurrence-following-pterygi-a7756

Similar Items

Topical cyclosporine A 0.05% before and after surgery to prevent pterygium recurrence
by: Roberta Lilian Fernandes de Sousa Meneghim, et al.

Topical application of 0.05% cyclosporine A as an adjunct to LASIK
by: E. V. Kudryashova, et al.
Published: (2015-12-01)

Exposição de fibroblastos da cápsula de Tenon de pterígios à ciclosporina 0,05% Exposure of Tenon's capsule fibroblasts of pterygium to cyclosporin 0.05%
by: Laura Almeida Hercules, et al.
Published: (2006-12-01)

Efficacy of topical carboxymethyl cellulose 0.5% and cyclosporine A 0.05% in dry eye syndrome
by: Sangeeta Shah, et al.
Published: (2017-01-01)

Efficacy of topical cyclosporine 0.05% eye drops in the treatment of dry eyes
by: Haitham Y Al-Nashar
Published: (2015-01-01)

FEATURES OF 0.05% CYCLOSPORINE (RESTASIS) APPLICATION IN TREATMENT OF RECURRENT INFILTRATIVE ADENOVIRAL KERATITIS
by: D. Y. Maychuk, et al.
Published: (2015-10-01)

Effect of topical 0.05% cyclosporine A on corneal endothelium in patients with dry eye disease
by: María Castro-Rebollo, et al.
Published: (2013-08-01)

Effect of 0.05% topical cyclosporine for the treatment of symptomatic subepithelial infiltrates due to adenoviral keratoconjunctivitis
by: Ilkay Kilic Muftuoglu, et al.
Published: (2016-04-01)

Effectiveness and Optical Quality of Topical 3.0% Diquafosol versus 0.05% Cyclosporine A in Dry Eye Patients following Cataract Surgery
by: Jang Hoon Lee, et al.
Published: (2016-01-01)

A Comparative Study of Efficacy and Safety of Topical Loteprednol Etabonate 0.5% and Cyclosporin A 0.05% for the Treatment of Vernal Keratoconjunctivitis
by: Sharika Ganjoo, et al.
Published: (2020-12-01)

Comparing the efficacy of 2% topical rebamipide and 0.1% topical sodium hyaluronate with or without 0.05% topical cyclosporine in patients with dry eye disease
by: Priyanka V Gandhi, et al.
Published: (2021-01-01)

Effect of topical 0.05% cyclosporine A on the tear protein lacritin in a rat model of dry eye
by: Fen-Dui Zhang, et al.
Published: (2019-02-01)

Retrospective Review on the Use of Topical Cyclosporin A 0.05% for Paediatric Allergic Conjunctivitis in Hong Kong Chinese
by: Macy M. S. Wu, et al.
Published: (2014-01-01)

Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children
by: Arkendu Chatterjee, et al.
Published: (2019-10-01)

Clinical efficacy of combined topical 0.05% cyclosporine A and 0.1% sodium hyaluronate in the dry eyes with meibomian gland dysfunction
by: Ho-Yun Kim, et al.
Published: (2018-04-01)

Comparison of Efficacy of Two Different Topical 0.05% Cyclosporine A Formulations in the Treatment of Adenoviral Keratoconjunctivitis-Related Subepithelial Infiltrates
by: Betül N. Bayraktutar, et al.
Published: (2016-03-01)

Cyclosporine a 0.05% eye drops for the treatment of subepithelial infiltrates after epidemic keratoconjunctivitis
by: Okumus Seydi, et al.
Published: (2012-08-01)

Eficácia da ciclosporina 0,05% na prevenção da perda endotelial no transplante de córnea Efficacy of cyclosporine 0.05% for preventing endothelial loss in corneal transplant
by: Fernando Moro, et al.
Published: (2007-10-01)

Efficacy and Safety of Topical Calcipotriol 0.005% Versus Topical Clobetasol 0.05% in the Management of Alopecia Areata: An Intrasubject Pilot Study
by: Elisa Molinelli, et al.
Published: (2020-04-01)

Uso de ciclosporina 0,05% tópica no tratamento do olho seco de pacientes portadores do vírus HIV Topical cyclosporine 0.05% for the treatment of dry eye disease in patients infected with the human immunodeficiency virus
by: Rodrigo de Pinho Paes Barreto, et al.
Published: (2009-04-01)

An Experience of Using Cyclosporin 0.05 % (Restasis) in Conjunctival Lymphangiectosia Treatment of Patients With Dry Eye Syndrome
by: S. A. Volik, et al.
Published: (2018-10-01)

Patient and physician perspectives on the use of cyclosporine ophthalmic emulsion 0.05% for the management of chronic dry eye
by: Deveney T, et al.
Published: (2018-03-01)

Efficacy of 0.05% cyclosporine A on the lipid layer and meibomian glands after cataract surgery: A randomized, double-masked study.
by: Min Seung Kang, et al.
Published: (2021-01-01)

Pharmacodynamic and Dermatopharmacokinetic Bioequivalence Studies of Topical 0.05% Clobetasol 17-Propionate
by: YiFang Tsai, et al.
Published: (2001)

Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam
by: Sharleen St. Surin-Lord, et al.
Published: (2020-01-01)

Study of Ce0.9Tb0.05Ln0.05O1.975 compounds as ceramic pigments
by: Šulcová P., et al.
Published: (2008-01-01)

Comparative assessment of topical steroids, topical tretenoin (0.05%) and dithranol paste in alopecia areata
by: Das Sudip, et al.
Published: (2010-01-01)

Effects of sintering temperature on structure, magnetic and dielectric properties of La0.5Sr0.5Fe0.9Mn0.05Ti0.05O3 material
by: Handoko Erfan, et al.
Published: (2018-01-01)

Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
by: Chang Hyun Park, et al.
Published: (2019-06-01)

PERSIST: Physician&#39;s Evaluation of Restasis&reg; Satisfaction in Second Trial of topical cyclosporine ophthalmic emulsion 0.05% for dry eye: a retrospective review
by: Mah F, et al.
Published: (2012-11-01)

Efficacy of 0.05% Chlorhexidine and 0.05% Cetylpyridinium Chloride Mouthwash to Eliminate Living Bacteria on In Situ Collected Biofilms: An In Vitro Study
by: Kathrin Becker, et al.
Published: (2021-06-01)

A study of refractory cases of persistent epithelial defects associated with dry eye syndrome and recurrent corneal erosions successfully treated with cyclosporine A 0.05% eye drops
by: Napoli PE, et al.
Published: (2019-06-01)

DTA-TG Analysis of Gd0.95La0.05Ba1.95Sr0.05Cu3Oy Compounds
by: Made Sumadiyasa, et al.
Published: (2020-02-01)

Evaluation of Intraocular Pressure Changes with Topical Dexamethasone 0.1%, Prednisolone 1% and Difluprednate 0.05% Postcataract Surgery- A Randomised Clinical Trial
by: Sachit Mahajan, et al.
Published: (2021-07-01)

Preclinical Efficacy Comparison of Cyclosporine Ophthalmic Solution 0.09% vs Cyclosporine Ophthalmic Emulsion 0.05% vs Ciclosporin Ophthalmic Emulsion 0.1% in a NOD Mouse Model of Dry Eye Disease
by: Burade V, et al.
Published: (2020-09-01)

RKKY magnetic interactions in chemically synthesized Zn0.95−xFe0.05AlxO (x = 0, 0.03, 0.05, 0.07) nanocrystallites
by: Shahid M. Ramay, et al.
Published: (2017-02-01)

FROM 0.5% TO 0.05%: ACHIEVING NEW LEVELS OF SENSOR ACCURACY IN AN AIRBORNE ENVIRONMENT
by: Sweeney, Paul
Published: (2004)

Retraction Note: Comparison of 0.05% cyclosporine and 3% diquafosol solution for dry eye patients: a randomized, blinded, multicenter clinical trial
by: Chang Hyun Park, et al.
Published: (2020-06-01)

Clinical utility of cyclosporine (CsA) ophthalmic emulsion 0.05% for symptomatic relief in people with chronic dry eye: a review of the literature
by: Rhee MK, et al.
Published: (2017-06-01)

Does topical bevacizumab prevent postoperative recurrence after pterygium surgery with conjunctival autografting?
by: Aylin Karalezli, et al.
Published: (2014-06-01)